Keep Patients Getting "Flozins" for Diabetes Safe

November 2018

New safety concerns are popping up about "flozins" (Invokana, Jardiance, Steglatro, etc) for type 2 diabetes.

Flozins are in the spotlight lately...since some may have heart and kidney protection benefits.

But flozins also have risks...such as yeast infections, urinary tract infections, low blood pressure, and rare fractures.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Med Safety Stop Common Rx Label Problems in Their Tracks
Vaccines Triage Questions About the New Shingles Vaccine Shingrix
Practice Combat Counterfeit Meds
E-Cigarettes Identify Adolescents Who Vape or Use E-Cigarettes
Communication Personalize Care for Millennial Patients
Pediatrics Expect to See Warnings About Breastfeeding Moms Using Methadone
Diabetes Meds Keep Patients Getting "Flozins" for Diabetes Safe
Dermatology Understand How Treatments for Profuse Sweating Compare
Aspirin Expect Fewer Patients to Take Low-Dose Aspirin
Pregnancy Anticipate Med Changes in Pregnant Women With Thyroid Disease